Image de couverture de livre

Analysis of immunoglobulin/T‐cell receptor repertoires by high‐throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Victor Bobée, Mathieu Viennot, Vinciane Rainville, Liana Veresezan, Fanny Drieux, Pierre‐Julien Viailly, Victor Michel, Vincent Sater, Marie‐Delphine Lanic, Elodie Bohers, Vincent Camus, Hervé Tilly, Fabrice Jardin, Philippe Ruminy
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	HemaSphere
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial
par: Simone Ragaini, et autres
Publié: (2026)

The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
par: Andrew D. Zelenetz, et autres
Publié: (2024)

Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups
par: Andrea Combalia, et autres
Publié: (2026)

Integration of gene mutations in risk prognostication for watch‐and‐wait follicular lymphoma patients initiating first‐line treatment
par: Tian‐Yuan Xu, et autres
Publié: (2025)

Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
par: Nawar Maher, et autres
Publié: (2026)

Accurate diagnosis of hemoglobinopathies with machine learning based on high‐throughput proteomics
par: Shaodong Wei, et autres
Publié: (2025)

Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
par: Alberto Bavieri, et autres
Publié: (2024)

Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early‐life DNMT3A mutations
par: Lucca L. M. Derks, et autres
Publié: (2025)

Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM‐2 study
par: Stefano Luminari, et autres
Publié: (2026)

Correction to “Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early‐life DNMT3A mutations”
Publié: (2026)

Efficacy and safety of the academic anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma
par: Núria Martínez‐Cibrián, et autres
Publié: (2025)

Persistent BCR::ABL1 ‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL
par: Jean‐Edouard Martin, et autres
Publié: (2026)

CHIC: A machine learning framework for inferring the presence of high‐risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants
par: William G. Dunn, et autres
Publié: (2025)

Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
par: Jean Galtier, et autres
Publié: (2025)

Distribution reappraisal of peripheral T‐ and NK‐cell lymphoma entities through the French Lymphopath network database
par: Thomas Grange, et autres
Publié: (2025)

Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study
par: Axel André, et autres
Publié: (2024)

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction
par: Vincent Kuek, et autres
Publié: (2026)

Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry
par: Jean Galtier, et autres
Publié: (2025)

Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
par: Maël Heiblig, et autres
Publié: (2025)

VHL, transferrin, and erythropoietin in the regulation of hepcidin
par: Ivan Sergeev, et autres
Publié: (2025)

Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up
par: Catherine Thieblemont, et autres
Publié: (2025)

Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
par: Pierre Sesques, et autres
Publié: (2026)

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
par: Sophie Le Grand, et autres
Publié: (2025)

HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia
par: Charles Toulemonde, et autres
Publié: (2025)

Interferon gamma‐mediated prevention of tumor progression in a mouse model of multiple myeloma
par: Zoltán Kellermayer, et autres
Publié: (2024)

Xq24/ IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B‐cell lymphoma
par: Lukas Marcelis, et autres
Publié: (2025)

Bridging gaps in clinical trial accessibility and reimbursement for large B‐cell lymphoma therapies across Europe
par: Florence Broussais, et autres
Publié: (2025)

Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
par: Meral Beksac, et autres
Publié: (2026)

Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
par: Mariana Bastos‐Oreiro, et autres
Publié: (2025)

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
par: Roger Mulet‐Lazaro, et autres
Publié: (2025)

Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study
par: Martijn W. C. Verbeek, et autres
Publié: (2025)

Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells
par: Gloria Iacoboni, et autres
Publié: (2024)

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
par: Amira Marouf, et autres
Publié: (2025)

Inflammatory disorders in IDH‐mutated myeloid neoplasms: Characteristics and response to IDH inhibitors
par: Romain Stammler, et autres
Publié: (2025)

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
par: Gloria Iacoboni, et autres
Publié: (2024)

Issue Information
Publié: (2025)

Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia
par: Raúl Córdoba, et autres
Publié: (2026)

Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
par: Anna Ossami Saidy, et autres
Publié: (2025)

Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes
par: Enrico Attardi, et autres
Publié: (2024)

Cell‐free DNA for detection and monitoring of extramedullary AML relapse
par: Henri C. Hupe, et autres
Publié: (2025)